In human genome-wide association studies of prodromal AD [94] and AD patients with mild cognitive impairment (MCI), high amounts of CCL2 were detected in the CSF and CCL2 levels correlated with a faster rate of cognitive decline in the analyzed patient cohort [95]. Here, CCL2 is linked to Alzheimer disease.